Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000141

Chairperson & CEO sold 9,500 shares at an average $504.12 ($4,789,152)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-14 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-14 Sale : show line 2 in the form 10b5-1 −1,580 $502.15 $793,399 332,363 I
2026-09-14 Sale : show line 3 in the form 10b5-1 −2,358 $503.44 $1,187,113 330,005 I
2026-09-14 Sale : show line 4 in the form 10b5-1 −2,722 $504.47 $1,373,180 327,283 I
2026-09-14 Sale : show line 5 in the form 10b5-1 −2,400 $505.25 $1,212,609 324,883 I
2026-09-14 Sale : show line 6 in the form 10b5-1 −440 $506.48 $222,851 324,443 I
Open-market sales · 9,500 sh · avg $504.12 · $4,789,152

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-14 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option −9,500 442,410 I
Loading xslF345X06/primarydocument.xml…